Latest filing published 12 Feb 2019 for Gossamer Bio, Inc., €102k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -11.9%Entry US$1,406.40 · Close at T+365 US$1,238.40
- -26.1%Entry US$251.75 · Close at T+365 US$186.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Russell J. Cox: trading record in brief
Russell J. Cox discloses dealings in 3 companies, chiefly Jazz Pharmaceuticals plc, Gossamer Bio, Inc. and Spyre Therapeutics, Inc. Between 31 May 2011 and 12 February 2019, the trades on record add up to 51 filings.
The open-market side counts 2 purchases for €164k alongside 15 sales for €3.1M. Netting one side against the other leaves €2.9M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 25 share grants and 5 option exercises. 2019 to date brings 1 purchase and no sales.
Most recently, on 12 February 2019, the filings show an open-market purchase worth €102k in Gossamer Bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Russell J. Cox
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,200 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-19-009452:0Canonical exit: 13 May 2019 (T+90)
- 44,200 shares@ US$8.238.0% of flowOrdinary SharesSEC:0001628280-17-012316:0
- 4,867 shares@ US$46.835.0% of flowOrdinary SharesSEC:0001628280-17-012316:1
- 1,691 shares@ US$59.132.2% of flowOrdinary SharesSEC:0001628280-17-012316:2
- 978 shares@ US$155.563.3% of flowOrdinary SharesSEC:0001512984-17-000005:0
- 1,793 shares@ US$132.815.8% of flowOrdinary SharesSEC:0001232524-17-000067:0
- 10,000 shares0Ordinary SharesSEC:0001232524-17-000057:0
- 2,507 shares@ US$136.978.4% of flowOrdinary SharesSEC:0001512984-17-000002:0
- 1,000 shares@ US$125.003.0% of flowOrdinary SharesSEC:0001232524-17-000004:0
- 3,000 shares@ US$130.009.4% of flowOrdinary SharesSEC:0001232524-17-000004:1
- 978 shares@ US$149.023.4% of flowOrdinary SharesSEC:0001232524-16-000307:0
- 4,565 shares@ US$150.0115.9% of flowOrdinary SharesSEC:0001232524-16-000307:1
- 4,000 shares@ US$148.6613.8% of flowOrdinary SharesSEC:0001232524-16-000307:2
- 4,000 shares@ US$136.9812.4% of flowOrdinary SharesSEC:0001512984-16-000004:0
- 7,000 shares@ US$10.00100.0% of flowCommon StockSEC:0001140361-16-060926:0Canonical exit: 11 Jul 2016 (T+90)
- 1,550 shares@ US$127.844.6% of flowOrdinary SharesSEC:0001232524-16-000242:0
- 939 shares@ US$121.582.7% of flowOrdinary SharesSEC:0001232524-16-000232:0
- 9,000 shares0Ordinary SharesSEC:0001232524-16-000199:0
- 731 shares@ US$125.002.1% of flowOrdinary SharesSEC:0001232524-16-000199:1
- 500 shares@ US$177.82Ordinary SharesSEC:0001209191-15-065648:0
- 978 shares@ US$181.79Ordinary SharesSEC:0001209191-15-065352:0
- 4,565 shares@ US$181.48Ordinary SharesSEC:0001209191-15-065352:1
- 500 shares@ US$181.45Ordinary SharesSEC:0001232524-15-000082:0
- 1,571 shares@ US$174.76Ordinary SharesSEC:0001232524-15-000056:0
- 500 shares@ US$175.10Ordinary SharesSEC:0001232524-15-000056:1
25 of 50 declarations
